These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 9010833)

  • 1. The effects of triethanolamine myristate, a fatty acid salt, on the bioavailability of riboflavin in dogs.
    Forusz H; Ritschel WA
    Methods Find Exp Clin Pharmacol; 1996 Nov; 18(9):589-91. PubMed ID: 9010833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of triethanolamine myristate, a fatty acid salt, on the availability of riboflavin in humans.
    Forusz H; Ritschel WA
    Methods Find Exp Clin Pharmacol; 1997; 19(1):73-6. PubMed ID: 9098843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Change of relative bioavailability of riboflavin by the fluid intake (author's transl)].
    Frömming KH; Mehnert W; Vetter G
    Arzneimittelforschung; 1981; 31(12):2159-62. PubMed ID: 7199319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of aminolevulinic acid after oral and intravenous administration in dogs.
    Dalton JT; Meyer MC; Golub AL
    Drug Metab Dispos; 1999 Apr; 27(4):432-5. PubMed ID: 10232930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bioavailability and pharmacokinetic analysis of riboflavin preparations on partially gastrotomized patients].
    Chen GS; Xi NZ
    Yao Xue Xue Bao; 1984 Mar; 19(3):208-12. PubMed ID: 6496093
    [No Abstract]   [Full Text] [Related]  

  • 6. Bioavailability of amoxicillin and clavulanic acid from extended release tablets depends on intragastric tablet deposition and gastric emptying.
    Weitschies W; Friedrich C; Wedemeyer RS; Schmidtmann M; Kosch O; Kinzig M; Trahms L; Sörgel F; Siegmund W; Horkovics-Kovats S; Schwarz F; Raneburger J; Mönnikes H
    Eur J Pharm Biopharm; 2008 Oct; 70(2):641-8. PubMed ID: 18582572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral mitemcinal (GM-611), an erythromycin-derived prokinetic, accelerates normal and experimentally delayed gastric emptying in conscious dogs.
    Onoma M; Yogo K; Ozaki K; Kamei K; Akima M; Koga H; Itoh Z; Omura S; Takanashi H
    Clin Exp Pharmacol Physiol; 2008 Jan; 35(1):35-42. PubMed ID: 18047625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of inhibiting cytochrome P450 3A, p-glycoprotein, and gastric acid secretion on the oral bioavailability of methadone in dogs.
    Kukanich B; Lascelles BD; Aman AM; Mealey KL; Papich MG
    J Vet Pharmacol Ther; 2005 Oct; 28(5):461-6. PubMed ID: 16207309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioavailability of riboflavin.
    Bates CJ
    Eur J Clin Nutr; 1997 Jan; 51 Suppl 1():S38-42. PubMed ID: 9023479
    [No Abstract]   [Full Text] [Related]  

  • 10. Phenylbutazone prevents the endotoxin-induced delay in gastric emptying in horses.
    Valk N; Doherty TJ; Blackford JT; Abraha TW; Frazier DL
    Can J Vet Res; 1998 Jul; 62(3):214-7. PubMed ID: 9684051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of cyclooxygenase-2 inhibitor on glucagon-induced delayed gastric emptying and gastric dysrhythmia in dogs.
    Xu J; Chen JD
    Neurogastroenterol Motil; 2007 Feb; 19(2):144-51. PubMed ID: 17244169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of EM574 and cisapride on gastric contractile and emptying activity in normal and drug-induced gastroparesis in dogs.
    Tanaka T; Mizumoto A; Mochiki E; Suzuki H; Itoh Z; Omura S
    J Pharmacol Exp Ther; 1998 Nov; 287(2):712-9. PubMed ID: 9808701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitemcinal (GM-611), an orally active motilin receptor agonist, improves delayed gastric emptying in a canine model of diabetic gastroparesis.
    Onoma M; Ozaki K; Yogo K; Monnai M; Muramatsu H; Kamei K; Kawabe Y; Hayashi S; Shiga T; Matsuo S; Suzuki M; Itoh Z; Omura S; Takanashi H
    Clin Exp Pharmacol Physiol; 2008 Jul; 35(7):788-96. PubMed ID: 18346169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastroretentive Accordion Pill: Enhancement of riboflavin bioavailability in humans.
    Kagan L; Lapidot N; Afargan M; Kirmayer D; Moor E; Mardor Y; Friedman M; Hoffman A
    J Control Release; 2006 Jul; 113(3):208-15. PubMed ID: 16806558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of liquid volume and food intake on the absolute bioavailability of danazol, a poorly soluble drug.
    Sunesen VH; Vedelsdal R; Kristensen HG; Christrup L; Müllertz A
    Eur J Pharm Sci; 2005 Mar; 24(4):297-303. PubMed ID: 15734296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel gastroretentive dosage forms: evaluation of gastroretentivity and its effect on riboflavin absorption in dogs.
    Klausner EA; Lavy E; Stepensky D; Friedman M; Hoffman A
    Pharm Res; 2002 Oct; 19(10):1516-23. PubMed ID: 12425470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitory effects of sildenafil on gastric motility and gastric slow waves in dogs.
    Zhu H; Xu X; Chen JD
    Neurogastroenterol Motil; 2007 Mar; 19(3):218-24. PubMed ID: 17300292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioavailability of riboflavin from a gastric retention formulation.
    Ahmed IS; Ayres JW
    Int J Pharm; 2007 Feb; 330(1-2):146-54. PubMed ID: 17034968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between acceleration of gastric emptying and oesophageal acid exposure in patients with endoscopy-negative gastro-oesophageal reflux disease.
    Carmagnola S; Fraquelli M; Cantù P; Conte D; Penagini R
    Scand J Gastroenterol; 2006 Jul; 41(7):767-72. PubMed ID: 16785188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of delaying gastric emptying on meal-related symptoms in healthy subjects.
    Tack J; Coulie B; Verbeke K; Janssens J
    Aliment Pharmacol Ther; 2006 Oct; 24(7):1045-50. PubMed ID: 16984498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.